Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Accumulated Expenses (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Accumulated Expenses for 2 consecutive years, with $39829.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 97.19% to $39829.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39829.0 through Dec 2025, down 97.19% year-over-year, with the annual reading at $39829.0 for FY2025, 97.19% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $39829.0 at Jupiter Neurosciences, up from $4350.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.9 million in Q2 2025, with the low at $4350.0 in Q3 2025.